Focus: Enable Injections is a Cincinnati-based biotechnology company specializing in wearable automated injector devices, with a focus on neurology applications. As a public-stage company founded in 2010, they operate in the medical device/biotech intersection.
Profile data last refreshed 5h ago · AI intelligence enriched 3w ago
Growing — net +5 jobs in 30d
6 jobs added vs 1 removed. Steady team buildout.
Enable Injections offers niche device innovation potential but carries significant execution and transparency risks; suitable only for candidates prioritizing deep technical ownership over career acceleration or financial stability visibility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Enable Injections
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Enable Injections's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo